Revision history of "Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models" (Q28478763)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

(latest | earliest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

25 August 2023

4 April 2023

2 October 2022

18 September 2022

11 June 2022

1 May 2021

29 July 2019

27 July 2019

29 March 2019

30 December 2018

13 December 2018

27 November 2018

1 November 2018

15 September 2018

2 June 2018

24 March 2018

27 October 2017

29 September 2017

16 September 2017

  • curprev 02:0202:02, 16 September 2017 Emijrpbot talk contribs 25,885 bytes +4,444 Updated Item: BOT - Adding descriptions (54 languages): ast, bg, bn, ca, cs, da, de, el, eo, es, et, fi, fr, gl, he, hu, it, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl,... undo (restore)

2 July 2017

29 May 2017

19 March 2017

25 February 2017

31 January 2017

25 January 2017

(latest | earliest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)